2026 Medicare Part D: what changed what it costs and what it means for seniors

01What changed in Medicare Part D for 2026

Medicare Part D is entering its second year under the Inflation Reduction Act's most visible redesign. The central change is a hard annual limit on a beneficiary's out-of-pocket spending for covered Part D drugs, alongside a new payment structure that spreads costs across the plan, manufacturers, and Medicare.

The rules are easier to describe than to experience. Plans still have formularies, tiers, prior authorization, pharmacies, premiums, and deductibles. A lower annual ceiling does not mean every prescription is cheap at the counter, and it does not eliminate the need to compare plans.

02The new out-of-pocket cap and how it works

For 2026, the Part D out-of-pocket threshold is an annually adjusted amount around $2,100, following the $2,000 limit established for 2025. Once a beneficiary's qualifying out-of-pocket spending reaches the cap, the plan's catastrophic phase begins and the beneficiary generally owes no additional cost sharing for covered Part D drugs for the rest of that year.

The cap is not based on every dollar a person spends on health care. It applies to covered Part D drugs and uses specific rules about which payments count. Premiums, drugs excluded from the plan's formulary, and some other expenses do not move a beneficiary toward the limit.

03How drug pricing reform affects Part D

Medicare's drug-price negotiation program is beginning with a limited group of high-spending medicines and expanding over time. Negotiated prices can reduce plan spending and, depending on the drug and plan design, may reduce what beneficiaries pay. The effect is not universal because the negotiated list does not include every medicine and plans still set formularies and networks.

The law also changes the incentives around catastrophic coverage. Plans assume a larger share of costs after the out-of-pocket limit, while manufacturers contribute discounts in certain phases. That structure is intended to limit beneficiary exposure while making plans and manufacturers bear more of the cost of very expensive treatment.

04What seniors pay under the new rules

A beneficiary's annual cost can still include a monthly premium, a deductible, coinsurance, and copayments before the cap is reached. Someone taking only inexpensive generics may never approach the limit, while a person taking several specialty drugs can reach it early in the year. The same drug can also have different costs across plans.

The practical question is therefore not simply, What is the cap? It is, How quickly will my prescriptions move me toward it, and what will I pay before then? Medicare's Plan Compare tool, the plan's evidence of coverage, and a pharmacist or counselor can help answer that with the actual medication list.

05The insulin and vaccine cost changes

The Part D insulin benefit continues to limit covered insulin cost sharing to no more than $35 for a month's supply in the relevant benefit phase. Adult vaccines covered by Part D, including vaccines recommended by the Advisory Committee on Immunization Practices, are generally available without cost sharing when obtained through the plan's covered process.

Those protections are important, but the details still matter. A beneficiary should verify that a pharmacy can bill the vaccine under Part D rather than Part B, and should ask the plan how a specific insulin product is covered. Coverage rules and preferred pharmacies can change from one plan to another.

06How to choose the right plan

Start with the full list of prescriptions, including dose and frequency, then check each plan's formulary and pharmacy network. Compare the annual premium, deductible, copays, coinsurance, utilization restrictions, mail-order options, and the estimated total annual cost rather than focusing on the premium alone.

People who expect high drug spending should also examine how the plan handles the month-by-month transition to the cap. A plan with a slightly higher premium may produce lower total costs if its tiers and preferred pharmacy fit the medication list better.

07What to watch for during enrollment

During annual enrollment, watch for changes in formularies, tier placement, pharmacy networks, premiums, deductibles, and estimated annual costs. A medicine that was preferred this year may move tiers next year, and a pharmacy that was in-network may no longer have the same status.

Do not wait until January to discover a problem. Save the plan's annual notice of change, confirm high-cost prescriptions before switching, and use Medicare's official comparison tools or State Health Insurance Assistance Program counseling when the choices are difficult.